Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine.
Patricia Hirt-MinkowskiJoelle HandschinSusanne StampfHelmut HopferThomas MenterLisa SennGideon HöngerCaroline WehmeierPatrizia AmicoJürg SteigerMichael KollerMichael DickenmannStefan SchaubPublished in: Journal of the American Society of Nephrology : JASN (2023)
This study could not demonstrate a beneficial effect of urine CXCL10 monitoring on one-year outcomes (ClinicalTrials.gov_NCT03140514).